Published: 7 September 2025Economy
US Pharma Tariffs Threaten India's Pharma Exports Worth Over $30 Billion
India's pharmaceutical sector faces growing pressure as the US imposed a 100% tariff on branded and patented pharmaceutical imports effective October 1, 2025. While generic drugs have been spared so far, the move has injected uncertainty into global supply chains.
India supplies generics to over 200 countries, with the US accounting for 31.35% of exports. Indian generics saved the US $219 billion in healthcare costs in 2022 and comprise over 90% of US prescriptions. Official data put India's pharmaceutical exports at USD 30.45 billion in calendar year 2025. The global generics market is projected to reach $614 billion by 2030. Separately, India's GST rationalisation effective September 22 reduced GST on many drugs from 12% to 5% or nil.
0
6-axis classification
CoverageInternationalSubjectEconomicExamBasic Computer Instructor · CET Graduation · CET Senior Secondary · EO/RO · LDC · Mahila Supervisor · Patwar · PTI · RAS · REET · RPSC SI · School Lecturer · Senior Computer Instructor · Senior Teacher · UPSC · Vanpal · Both
Practice MCQ from this story
SolveTap an option below. Correct or incorrect feedback appears instantly.
Linked questionMedium
To what level did the US lower its reciprocal tariff on India in the February 2026 trade deal?
Explanation · Correct answer CThe February 2026 United States-India joint statement said the United States would apply an 18% reciprocal tariff rate on originating goods of India covered by the arrangement. Therefore, option C is correct.
Frequently asked questions
How do US pharma tariffs threaten India's generic drug exports?
**US imposed 100% tariff on branded and patented pharmaceutical imports effective October 1, 2025; generic drugs spared so far**. US proposed pharmaceutical tariffs threaten India's generic drug exports worth $25 billion to the American market.
What is the value of India's generic drug exports to the USA?
**India's generic drug exports to the USA are worth $25 billion**, making America India's largest pharmaceutical export market. **India supplies generics to 200+ countries; US accounts for 31.35% of pharma exports**
Why is India called the pharmacy of the world?
**India is the world's largest supplier of generic medicines**, accounting for 20% of global generic drug exports by volume. **Indian generics saved US $219 billion in healthcare costs in 2022 and comprise over 90% of US prescr**
How would US pharmaceutical tariffs impact American consumers?
**India's pharma exports contribute approximately $25 billion annually; global generics market projected at $614 billion by 2030**. Higher tariffs on Indian generics would raise drug prices for American consumers who depend on affordable generics.
What is India's response to potential US pharmaceutical tariffs?
**India's GST rationalisation (September 22) reduced tax on drugs from 12% to 5% in response**. India is engaging diplomatically with the US to highlight mutual dependence and the impact on American healthcare affordability.
